Kolexia
Rucheton Benoit
Pharmacien
Institut Bergonié
Bordeaux, France
58 Activités
24 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies mitochondriales Maladies musculaires Maladie d'Alzheimer Démence frontotemporale Épilepsie Démence Ataxie Myopathies mitochondriales Dégénérescence lobaire frontotemporale

Industries

Santhera
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

MITODIAG: A French network of diagnostic laboratories for mitochondrial diseases
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Neurobiology of disease   30 mars 2023
Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseases.
Annales de biologie clinique   02 décembre 2022
Neurofilaments: a key new biomarker for clinicians. Part 1: Importance of neurofilaments in the management of neurodegenerative diseases.
Annales de biologie clinique   02 décembre 2022
Neurofilaments contribution in clinic: state of the art.
Frontiers in aging neuroscience   01 novembre 2022
Highly asymmetrical distribution of muscle wasting correlates to the heteroplasmy in a patient carrying a large-scale mitochondrial DNA deletion: a novel pathophysiological mechanism for explaining asymmetry in mitochondrial myopathies.
Neuromuscular disorders : NMD   27 octobre 2022
Clinico-biological markers for the prognosis of status epilepticus in adults.
Journal of neurology   29 juin 2022
Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus.
Journal of neurology   21 février 2022
Diagnostic approach in adult-onset neurometabolic diseases.
Journal of neurology, neurosurgery, and psychiatry   09 février 2022
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Alzheimer's Association International Conference 2021   31 décembre 2021